{"id":5297,"date":"2018-01-07T15:30:41","date_gmt":"2018-01-07T15:30:41","guid":{"rendered":"https:\/\/aidsconcern.org.hk\/?page_id=5297"},"modified":"2021-08-14T23:41:48","modified_gmt":"2021-08-14T15:41:48","slug":"prevention","status":"publish","type":"page","link":"https:\/\/aidsconcern.org.hk\/zh\/help-and-support\/prevention\/","title":{"rendered":"\u9810\u9632\u65b9\u6cd5"},"content":{"rendered":"

[vc_row equal_height=”yes” css=”.vc_custom_1516820416215{padding-top: 80px !important;}”][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_column_text font_size=”larger”]<\/p>\n

\u7d9c\u5408\u5f62\u5f0f\u9810\u9632<\/h2>\n

\u300a\u806f\u5408\u570b\u611b\u6ecb\u75c5\u898f\u5283\u7f72\u300b\u652f\u6301\u4ee5\u7d9c\u5408\u5f62\u5f0f\u9810\u9632\u611b\u6ecb\u75c5\u75c5\u6bd2\u50b3\u64ad\u3002\u7d9c\u5408\u5f62\u5f0f\u9810\u9632\u6307\u4e00\u7cfb\u5217\u9810\u9632\u611b\u6ecb\u75c5\u75c5\u6bd2\u611f\u67d3\u7684\u65b9\u6cd5\uff0c\u7576\u4e2d\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u6b63\u78ba\u6301\u7e8c\u4f7f\u7528\u5b89\u5168\u5957\u3001\u5b9a\u671f\u611b\u6ecb\u75c5\u75c5\u6bd2\u6e2c\u8a66\u3001\u4f7f\u7528\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5(PrEP)\u53ca\u66b4\u9732\u5f8c\u9810\u9632\u6027\u6295\u85e5(PEP)\u3001\u611f\u67d3\u8005\u9ad4\u5167\u75c5\u6bd2\u6578\u91cf\u9054\u81f4\u4e0d\u53ef\u6aa2\u6e2c(Undetectable Viral Load)\u72c0\u614b\u4ee5\u53ca\u4f34\u4fb6\u5b89\u5168\u5354\u5546(Negotiated Safety) \u7b49\u3002\u5404\u7a2e\u9810\u9632\u611b\u6ecb\u75c5\u75c5\u6bd2\u50b3\u64ad\u63aa\u65bd\u53ef\u6309\u4e0d\u540c\u793e\u7fa4\u9700\u8981\u7d9c\u5408\u4f7f\u7528\uff0c\u4ee5\u9054\u81f4\u5168\u9762\u53ca\u6709\u6548\u7684\u611b\u6ecb\u75c5\u75c5\u6bd2\u9810\u9632\u3002<\/p>\n

\u53e6\u5916\uff0c\u9999\u6e2f\u611b\u6ecb\u75c5\u9867\u554f\u5c40\u5efa\u8b70\u7b56\u7565\u6307\u51fa\u6c92\u6709\u55ae\u4e00\u7684\u9810\u9632\u7b56\u7565\u8db3\u4ee5\u63a7\u5236\u611b\u6ecb\u75c5\u75ab\u60c5\u3002\u56e0\u6b64\u95dc\u61f7\u611b\u6ecb\u5efa\u8b70\u6240\u6709\u9ad8\u98a8\u96aa\u793e\u7fa4\u4eba\u58eb\u63a1\u53d6\u81f3\u5c11\u5169\u9805\u6216\u4ee5\u4e0a\u7684\u9810\u9632\u63aa\u65bd\uff0c\u624d\u53ef\u4ee5\u6709\u6548\u9810\u9632\u611b\u6ecb\u75c5\u75c5\u6bd2\u611f\u67d3\u3002<\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1516894044364{padding-top: 80px !important;padding-bottom: 40px !important;}” min_height=”500″][vc_column][vc_tta_tabs style=”engage_boxed” shape=”square” alignment=”center” active_section=”1″][vc_tta_section title=”\u6b63\u78ba\u6301\u7e8c\u4f7f\u7528\u5b89\u5168\u5957” tab_id=”1516819540166-48f81bda-52171f7d-6cbf45bd-95b2″][vc_row_inner][vc_column_inner][vc_column_text]\u5b89\u5168\u5957\u662f\u7c21\u55ae\u4f7f\u7528\u9810\u9632\u611b\u6ecb\u75c5\u75c5\u6bd2\u50b3\u64ad\u7684\u7528\u5177\uff0c\u53ea\u8981\u6301\u7e8c\u53ca\u6b63\u78ba\u5730\u4f7f\u7528\u5b89\u5168\u5957\u5c07\u6709\u6548\u9810\u9632\u611b\u6ecb\u75c5\u75c5\u6bd2\u50b3\u64ad\u3002\u6642\u81f3\u4eca\u65e5\uff0c\u5b89\u5168\u5957\u4f7f\u7528\u4ecd\u7136\u662f\u611b\u6ecb\u75c5\u9810\u9632\u63aa\u65bd\u4e2d\u4e3b\u8981\u7684\u7528\u51771<\/sup>\u00a0\u3002[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=”\u5b9a\u671f\u611b\u6ecb\u75c5\u75c5\u6bd2\u6e2c\u8a66” tab_id=”1516819540186-b9ce80ae-423a1f7d-6cbf45bd-95b2″][vc_row_inner][vc_column_inner][vc_column_text]\u611b\u6ecb\u75c5\u75c5\u6bd2\u6e2c\u8a66\u662f\u552f\u4e00\u6709\u6548\u7684\u6aa2\u67e5\u4e86\u89e3\u500b\u4eba\u7684\u611b\u6ecb\u75c5\u75c5\u6bd2\u72c0\u6cc1\u3002\u56e0\u6b64\uff0c\u95dc\u61f7\u611b\u6ecb\u9f13\u52f5\u66fe\u7d93\u767c\u751f\u4e0d\u5b89\u5168\u6027\u884c\u70ba\u7684\u4eba\u58eb\u65bc\u7a7a\u7a97\u671f\u5f8c\u5118\u5feb\u63a5\u53d7\u611b\u6ecb\u75c5\u75c5\u6bd2\u6e2c\u8a66\u3002\u6027\u6d3b\u8e8d\u4eba\u58eb\u6bcf\u516d\u500b\u6708\u4fbf\u53ef\u63a5\u53d7\u4e00\u6b21\u611b\u6ecb\u75c5\u75c5\u6bd2\u6e2c\u8a662<\/sup>\u00a0\u3002\u5404\u975e\u653f\u5e9c\u7d44\u7e54\u53ca\u653f\u5e9c\u5747\u6709\u63d0\u4f9b\u611b\u6ecb\u75c5\u75c5\u6bd2\u6e2c\u8a66\u4ee5\u53ca\u81ea\u9858\u8f14\u5c0e\u670d\u52d9\u3002\u53e6\u5916\uff0c\u5168\u7403\u5df2\u6709\u56db\u5957\u81ea\u6211\u6aa2\u6e2c\uff08\u5bb6\u7528\u6e2c\u8a66\uff09\u914d\u4ef6\u7372\u5168\u7403\u91ab\u7642\u5668\u6750\u6cd5\u898f\u8abf\u548c\u6703\u7684\u6210\u54e1\u7d44\u7e54\u6279\u51c63<\/sup>\u00a0\uff0c\u95dc\u61f7\u611b\u6ecb\u4ea6\u70ba\u9032\u884c\u81ea\u6211\u6aa2\u6e2c\u4eba\u58eb\u63d0\u4f9b\u8f14\u5c0e\u53ca\u8ddf\u9032\u670d\u52d9\u3002[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=”\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5(PrEP)” tab_id=”1543661883411-73792914-c6e8″][vc_row_inner][vc_column_inner][vc_column_text]\u5982\u679c\u6301\u7e8c\u670d\u7528\uff0c\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5\u80fd\u5920\u6709\u6548\u6e1b\u4f4e\u7d93\u6027\u884c\u70ba\u611f\u67d3\u611b\u6ecb\u75c5\u75c5\u6bd2\u7684\u98a8\u96aa\u3002\u6709\u9452\u65bc\u6295\u85e5\u6709\u6548\u6027\u7684\u8b49\u64da4 5<\/sup>\u00a0\uff0c\u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3(CDC)\u4ee5\u53ca\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO)\u5747\u8996\u63a5\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5\u70ba\u4e00\u7a2e\u9810\u9632\u611b\u6ecb\u75c5\u611f\u67d3\u7684\u91cd\u8981\u984d\u5916\u63aa\u65bd\u3002<\/p>\n

\u5982\u60f3\u4e86\u89e3\u66f4\u591a\uff0c\u8acb\u6309\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=”\u66b4\u9732\u5f8c\u9810\u9632\u6027\u6295\u85e5(PEP)” tab_id=”1516819540208-96688566-38631f7d-6cbf45bd-95b2″][vc_row_inner][vc_column_inner][vc_column_text]\u9019\u5169\u7a2e\u6295\u85e5\u80fd\u5728\u6e1b\u4f4e\u611b\u6ecb\u75c5\u75c5\u6bd2\u75ab\u60c5\u626e\u6f14\u91cd\u8981\u89d2\u8272\u3002\u5982\u679c\u6301\u7e8c\u670d\u7528\uff0c\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5\u80fd\u5920\u6709\u6548\u6e1b\u4f4e\u7d93\u6027\u884c\u70ba\u611f\u67d3\u611b\u6ecb\u75c5\u75c5\u6bd2\u7684\u98a8\u96aa\u3002\u6709\u9452\u65bc\u6295\u85e5\u6709\u6548\u6027\u7684\u8b49\u64da4 5<\/sup>\u00a0\uff0c\u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3(CDC)\u4ee5\u53ca\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO)\u5747\u8996\u66b4\u9732\u524d\u9810\u9632\u6027\u6295\u85e5\u70ba\u4e00\u7a2e\u9810\u9632\u611b\u6ecb\u75c5\u611f\u67d3\u7684\u91cd\u8981\u984d\u5916\u63aa\u65bd\u3002\u66b4\u9732\u5f8c\u9810\u9632\u6027\u6295\u85e5\u662f\u4e00\u7a2e\u6297\u611b\u6ecb\u75c5\u75c5\u6bd2\u85e5\u7269\uff0c\u5728\u7591\u4f3c\u63a5\u89f8\u611b\u6ecb\u75c5\u75c5\u6bd2\u5f8c 72 \u5c0f\u6642\u5167\u670d\u7528\uff0c\u80fd\u6709\u6548\u6e1b\u4f4e\u611f\u67d3\u98a8\u96aa\u905481%\u00a06<\/sup>\u3002[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=”\u9054\u81f4\u4e0d\u53ef\u6aa2\u6e2c\u75c5\u6bd2\u91cf(Undetectable Viral Load)\u72c0\u614b” tab_id=”1516819540228-f8d1f21a-77601f7d-6cbf45bd-95b2″][vc_row_inner][vc_column_inner][vc_column_text]\u7576\u611b\u6ecb\u75c5\u75c5\u6bd2\u611f\u67d3\u8005\u6301\u7e8c\u53ca\u6b63\u78ba\u5730\u670d\u7528\u6297\u9006\u8f49\u9304\u75c5\u6bd2\u7642\u6cd5(antiretroviral therapy)\uff0c\u5c07\u6709\u6548\u5730\u6e1b\u5c11\u611f\u67d3\u8005\u8840\u6db2\u5167\u7684\u75c5\u6bd2\u91cf\uff0c\u4e26\u5c07\u611b\u6ecb\u75c5\u75c5\u6bd2\u91cf\u9054\u81f4\u4e0d\u53ef\u6aa2\u6e2c\u6c34\u5e73\u3002\u9019\u6709\u6548\u5c07\u50b3\u64ad\u98a8\u96aa\u5927\u5927\u6e1b\u4f4e\u00a07<\/sup>\u3002\u6839\u64daPARTNER Study8<\/sup>\u7814\u7a76\u986f\u793a\uff0c\u9054\u81f4\u4e0d\u80fd\u6aa2\u6e2c\u75c5\u6bd2\u91cf\u7684\u611b\u6ecb\u75c5\u75c5\u6bd2\u611f\u67d3\u8005\u50b3\u64ad\u611b\u6ecb\u75c5\u75c5\u6bd2\u6a5f\u6703\u63a5\u8fd1\u96f6\uff0c\u6545\u6b64\u76e1\u65e9\u63a5\u53d7\u6cbb\u7642\u5c07\u6709\u6548\u7ba1\u7406\u8eab\u9ad4\u72c0\u6cc1\u53ca\u9810\u9632\u75c5\u6bd2\u50b3\u64ad\u3002[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=”\u4f34\u4fb6\u5b89\u5168\u5354\u5546(Negotiated Safety)” tab_id=”1516884835960-5d0c440e-a34645bd-95b2″][vc_column_text]\u4f34\u4fb6\u5b89\u5168\u5354\u5546\u8981\u6c42\u4f34\u4fb6\u4e4b\u9593\u9700\u8981\u6301\u7e8c\u6e9d\u901a\u53ca\u6e2c\u8a66\u3002\u9996\u5148\uff0c\u4f34\u4fb6\u9593\u9700\u8981\u8a0e\u8ad6\u5b89\u5168\u5957\u4f7f\u7528\u7684\u610f\u9858\uff0c\u4e86\u89e3\u96d9\u65b9\u5c0d\u65bc\u4f7f\u7528\u5b89\u5168\u5957\u7684\u611f\u53d7\u3002\u5176\u6b21\uff0c\u96d9\u65b9\u5747\u9700\u8981\u6301\u7e8c\u9032\u884c\u6e2c\u8a66\u3002\u5047\u82e5\u6c7a\u5b9a\u4e0d\u4f7f\u7528\u5b89\u5168\u5957\u767c\u751f\u6027\u884c\u70ba\uff0c\u5247\u5fc5\u9808\u9032\u884c\u6e2c\u8a66(\u7a7a\u7a97\u671f\u5167\u5247\u9700\u8981\u6301\u7e8c\u4f7f\u7528\u5b89\u5168\u5957)\u4ee5\u78ba\u5b9a\u4e26\u6c92\u6709\u611f\u67d3\u611b\u6ecb\u75c5\u75c5\u6bd2\u3002[\/vc_column_text][\/vc_tta_section][\/vc_tta_tabs][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1516885304955{padding-bottom: 80px !important;}”][vc_column][vc_column_text font_size=”small”]*\u4ee5\u4e0a\u63aa\u65bd\u53ea\u9069\u7528\u65bc\u611b\u6ecb\u75c5\u75c5\u6bd2\u9810\u9632\uff0c\u4e26\u4e0d\u5b8c\u5168\u9069\u7528\u65bc\u5176\u4ed6\u6027\u75c5\u7684\u9810\u9632\u3002<\/strong><\/span><\/p>\n

[1]\u00a0Joint United Nations Programme on HIV\/AIDS (2015). FAST-TRACKING COMBINATION PREVENTION. Available at: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20151019_JC2766_Fast-tracking_combination_prevention.pdf
\n<\/a><\/span>[2]\u00a0Joint United Nations Programme on HIV\/AIDS (2015). Combination HIV Prevention: Tailoring and Coordinating Biomedical, Behavioural and Structural Strategies 10 to Reduce New HIV Infections. Available at: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2007_Combination_Prevention_paper_en_0.pdf
\n<\/a><\/span>[3]\u00a0Joint United Nations Programme on HIV\/AIDS (2017). Public health and HIV viral load suppression. Available at: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20170724_viral_load_suppression_brochure.pdf
\n<\/a><\/span>[4] Dara A Lehman. (2015) Risk of drug resistance among persons acquiring HIV within a randomized trial of single-or-dual-agent pre-exposure prophylaxis. Journal of Infectious Disease, Vol 11, Issue 8, pp.1211-1218<\/span>
\n[5] Anderson PL, Glidden DV, Liu A, et al. (2012) Emtricitabine-tenofovir concentrations and preexposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine. Vol 4, Issue 151.<\/span>
\n[6] Centres for Disease Control and Prevention. (Jan 2005). Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services. Available at:\u00a0http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5402a1.htm
\n<\/a>[7] Rodger A. Association between sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy: the PARTNER study. 21st International AIDS Conference, Durban, abstract TUAC0206, 2016.<\/span>
\n[8] Rodger A et al.\u00a0HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study.\u00a0<\/em>21st Conference on\u00a0Retroviruses\u00a0and Opportunistic Infections, Boston, abstract 153LB, 2014.<\/span>
\n[9] ACON (2017). Know Your Risk | Ending HIV. Available at:\u00a0https:\/\/endinghiv.org.au\/nsw\/stay-safe\/risk-reduction-strategies\/<\/a>\u00a0.<\/span>[\/vc_column_text][\/vc_column][\/vc_row]